Hepatoprotective potential of isoquercitrin against type 2 diabetes-induced hepatic injury in rats

Non-alcoholic fatty liver disease is a main complication of type 2 diabetes. Isoquercitrin are employed for antidiabetic therapies, but the effects on liver function and the hepatocytes are unclear. The aim of this study was to investigate the effects of isoquercitrin on the T2DM-induced hepatic inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiao-Li, He, Yang, Ji, Li-Li, Wang, Kai-Yu, Wang, Yi-Li, Chen, De-Fang, Geng, Yi, OuYang, Ping, Lai, Wei-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731895/
https://www.ncbi.nlm.nih.gov/pubmed/29254185
http://dx.doi.org/10.18632/oncotarget.21074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731895/
https://www.ncbi.nlm.nih.gov/pubmed/29254185
http://dx.doi.org/10.18632/oncotarget.21074

Ejemplares similares